KR20100089632A - 마이크로스피어와 하이드로겔을 포함하는 서방성 약물전달 복합체 - Google Patents
마이크로스피어와 하이드로겔을 포함하는 서방성 약물전달 복합체 Download PDFInfo
- Publication number
- KR20100089632A KR20100089632A KR1020090008966A KR20090008966A KR20100089632A KR 20100089632 A KR20100089632 A KR 20100089632A KR 1020090008966 A KR1020090008966 A KR 1020090008966A KR 20090008966 A KR20090008966 A KR 20090008966A KR 20100089632 A KR20100089632 A KR 20100089632A
- Authority
- KR
- South Korea
- Prior art keywords
- drug
- hydrogel
- hsp27
- delivery
- microspheres
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
- 전달 약물; 및 하이드로겔(hydrogel) 내의 마이크로스피어(microsphere)를 포함하는 서방성 약물전달 복합체.
- 제 1 항에 있어서, 전달 약물은 마이크로스피어 또는 마이크로스피어와 하이드로겔 둘 다에 함유되어 있는 것을 특징으로 하는 서방성 약물전달 복합체.
- 제 1 항 또는 제 2 항에 있어서, 마이크로스피어와 하이드로겔은 중량비로 0.2 내지 5.0 범위인 것을 특징으로 하는 서방성 약물전달 복합체.
- 제 1 항 또는 제 2 항에 있어서, 전달 약물은 화학 약제, 단백질 및 유전자로 구성된 군으로부터 선택되는 제제인 것을 특징으로 하는 서방성 약물전달 복합체.
- 제 1 항 또는 제 2 항에 있어서, 전달 약물을 2 종 이상의 서로 다른 약물인 것을 특징으로 하는 서방성 약물전달 복합체.
- a) 전달 약물을 포함하는 마이크로스피어를 제공하는 단계; 및b) 마이크로스피어를 균질로 포함하도록 하여 하이드로겔을 형성하는 단계; 를 포함하는 서방성 약물전달 복합체의 제조 방법.
- 제 6 항에 있어서, b) 단계에서 하이드로겔 내에 전달 약물을 더 포함하도록 하여 하이드로 겔을 형성하는 것을 특징으로 하는 서방성 약물전달 복합체의 제조 방법.
- 제 6 항 또는 제 7 항에 있어서, 전달 약물은 화학 약제, 단백질 및 유전자로 구성된 군으로부터 선택되는 제제인 것을 특징으로 하는 서방성 약물전달 복합체의 제조 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090008966A KR101125029B1 (ko) | 2009-02-04 | 2009-02-04 | 마이크로스피어와 하이드로겔을 포함하는 서방성 약물전달 복합체 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090008966A KR101125029B1 (ko) | 2009-02-04 | 2009-02-04 | 마이크로스피어와 하이드로겔을 포함하는 서방성 약물전달 복합체 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100089632A true KR20100089632A (ko) | 2010-08-12 |
KR101125029B1 KR101125029B1 (ko) | 2012-07-09 |
Family
ID=42755498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090008966A KR101125029B1 (ko) | 2009-02-04 | 2009-02-04 | 마이크로스피어와 하이드로겔을 포함하는 서방성 약물전달 복합체 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101125029B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018190687A1 (ko) * | 2017-04-14 | 2018-10-18 | 한국기계연구원 | 구형 세라믹 과립의 제조방법 |
CN109674740A (zh) * | 2019-01-28 | 2019-04-26 | 安徽科昂纳米科技有限公司 | 一种气凝胶-水凝胶复合药物载体的制备方法及制得的载体 |
WO2019143205A1 (ko) * | 2018-01-19 | 2019-07-25 | 한양대학교 산학협력단 | 활물질을 담지한 에어로겔, 이와 하이드로겔의 복합체 |
KR20190088918A (ko) * | 2018-01-19 | 2019-07-29 | 한양대학교 산학협력단 | 활물질을 담지한 에어로겔, 이와 하이드로겔의 복합체 |
-
2009
- 2009-02-04 KR KR1020090008966A patent/KR101125029B1/ko active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018190687A1 (ko) * | 2017-04-14 | 2018-10-18 | 한국기계연구원 | 구형 세라믹 과립의 제조방법 |
US11801222B2 (en) | 2017-04-14 | 2023-10-31 | Korea Institute Of Materials Science | Manufacturing method for granule |
WO2019143205A1 (ko) * | 2018-01-19 | 2019-07-25 | 한양대학교 산학협력단 | 활물질을 담지한 에어로겔, 이와 하이드로겔의 복합체 |
KR20190088918A (ko) * | 2018-01-19 | 2019-07-29 | 한양대학교 산학협력단 | 활물질을 담지한 에어로겔, 이와 하이드로겔의 복합체 |
CN111630085A (zh) * | 2018-01-19 | 2020-09-04 | 汉阳大学校产学协力团 | 载有活性材料的气凝胶及水凝胶和气凝胶的复合物 |
CN111630085B (zh) * | 2018-01-19 | 2024-01-12 | 汉阳大学校产学协力团 | 载有活性材料的气凝胶及水凝胶和气凝胶的复合物 |
US11918711B2 (en) | 2018-01-19 | 2024-03-05 | Industry-University Cooperation Foundation Hanyang University | Aerogel carrying active material and composite of hydrogel and the aerogel |
CN109674740A (zh) * | 2019-01-28 | 2019-04-26 | 安徽科昂纳米科技有限公司 | 一种气凝胶-水凝胶复合药物载体的制备方法及制得的载体 |
Also Published As
Publication number | Publication date |
---|---|
KR101125029B1 (ko) | 2012-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction | |
Gao et al. | Defensins: The natural peptide antibiotic | |
Li et al. | Tailoring materials for modulation of macrophage fate | |
Wu et al. | Injectable and pH-responsive silk nanofiber hydrogels for sustained anticancer drug delivery | |
Lindsey et al. | Beta hairpin peptide hydrogels as an injectable solid vehicle for neurotrophic growth factor delivery | |
Soukasene et al. | Antitumor activity of peptide amphiphile nanofiber-encapsulated camptothecin | |
Mo et al. | Controlled dual delivery of angiogenin and curcumin by electrospun nanofibers for skin regeneration | |
Zilony et al. | Prolonged controlled delivery of nerve growth factor using porous silicon nanostructures | |
Wang et al. | Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds | |
Schnaider et al. | Enhanced nanoassembly-incorporated antibacterial composite materials | |
Wickremasinghe et al. | Controlled angiogenesis in peptide nanofiber composite hydrogels | |
Kang et al. | Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs | |
JP2020121977A (ja) | 疎水性薬物担体および抗菌剤としての使用のための両親媒性ペプチドナノ微粒子 | |
Yu et al. | A thermo-sensitive injectable hydroxypropyl chitin hydrogel for sustained salmon calcitonin release with enhanced osteogenesis and hypocalcemic effects | |
Chen et al. | Nanocomposites drug delivery systems for the healing of bone fractures | |
US11497833B2 (en) | Self-assembling peptides comprising non-Ionic polar amino acids | |
Santos et al. | Genetically engineered elastin-based biomaterials for biomedical applications | |
Shin et al. | Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis | |
Khan et al. | Perspective insights to bio-nanomaterials for the treatment of neurological disorders | |
Kumari et al. | Recombinant spider silk hydrogels for sustained release of biologicals | |
Wu et al. | Effects of RGD-grafted phosphatidylserine-containing liposomes on the polarization of macrophages and bone tissue regeneration | |
KR101125029B1 (ko) | 마이크로스피어와 하이드로겔을 포함하는 서방성 약물전달 복합체 | |
CN108473555A (zh) | 条件活性多肽 | |
Wang et al. | Targeting macrophage polarization as a promising therapeutic strategy for the treatment of osteoarthritis | |
Steinhagen et al. | Matrix metalloproteinase 9 (MMP-9) mediated release of MMP-9 resistant stromal cell-derived factor 1α (SDF-1α) from surface modified polymer films |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20141203 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20151214 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180102 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190102 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 9 |